Inventor
DENNIS MARK
US46 patents
⚠️ This page may combine multiple inventors who share the name “DENNIS MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
28 patentsUS9896506B2Feb 20, 2018
Anti-CD79B antibodies and immunoconjugates and methods of use
GENENTECH INC17 citations94
US9518118B2Dec 13, 2016
Anti-HER2 antibodies and immunoconjugates
GENENTECH INC22 citations92
US9611323B2Apr 4, 2017
Low affinity blood brain barrier receptor antibodies and uses therefor
GENENTECH INC40 citations90
US10494432B2Dec 3, 2019
Anti-CD79B antibodies and immunoconjugates and methods of use
GENENTECH INC5 citations84
US10179820B2Jan 15, 2019
Anti-HER2 antibodies and immunoconjugates
GENENTECH INC6 citations83
US8771966B2Jul 8, 2014
Immuno-PET imaging of antibodies and immunoconjugates and uses therefor
GENENTECH INC17 citations83
US10752703B2Aug 25, 2020
Anti-tryptase antibodies, compositions thereof, and uses thereof
GENENTECH INC7 citations81
US10941215B2Mar 9, 2021
Low affinity blood brain barrier receptor antibodies and uses thereof
GENENTECH INC6 citations79
US11866496B2Jan 9, 2024
Humanized anti-CD79B antibodies and immunoconjugates and methods of use
GENENTECH INC1 citations73
USRE48558EMay 18, 2021
Anti-CD79B antibodies and immunoconjugates and methods of use
GENENTECH INC2 citations73
US10981987B2Apr 20, 2021
Humanized anti-CD79b antibodies and immunoconjugates and methods of use
GENENTECH INC4 citations73
US10544218B2Jan 28, 2020
Anti-CD79B antibodies and immunoconjugates and methods of use
GENENTECH INC4 citations73
US9266955B2Feb 23, 2016
Anti-FGFR4 antibodies and methods of use
GENENTECH INC5 citations73
US10556966B2Feb 11, 2020
Anti-HER2 antibodies and immunoconjugates
GENENTECH INC2 citations72
US10314846B2Jun 11, 2019
Immunoconjugates comprising anti-HER2 antibodies and pyrrolobenzodiazepines
GENENTECH INC2 citations72
US9719996B2Aug 1, 2017
Anti-mesothelin antibodies and immunoconjugates
GENENTECH INC2 citations72
US11939396B2Mar 26, 2024
Anti-tryptase antibodies, compositions thereof, and uses thereof
GENENTECH INC1 citations70
US10738131B2Aug 11, 2020
Anti-tryptase antibodies, compositions thereof, and uses thereof
GENENTECH INC2 citations70
US12583937B2Mar 24, 2026
Compositions and methods for the diagnosis and treatment of tumor
GENENTECH INC0 citations62
US12492263B2Dec 9, 2025
Anti-HER2 antibodies and immunoconjugates
GENENTECH INC0 citations62
US10377825B2Aug 13, 2019
Anti-HER2 antibodies and methods of use
GENENTECH INC1 citations59
US9994643B2Jun 12, 2018
Compositions and methods for the diagnosis and treatment of tumor
GENENTECH INC0 citations52
US9029511B2May 12, 2015
Compositions and methods for the diagnosis and treatment of tumor
GENENTECH INC0 citations52
US8871911B2Oct 28, 2014
Compositions and methods for the diagnosis and treatment of tumor
GENENTECH INC0 citations52
US10022452B2Jul 17, 2018
Anti-mesothelin antibodies and immunoconjugates
GENENTECH INC0 citations51
US10633650B2Apr 28, 2020
Expression and secretion system
GENENTECH INC0 citations50
US9803191B2Oct 31, 2017
Expression and secretion system
GENENTECH INC0 citations50
US11167038B2Nov 9, 2021
Methods for improving safety of blood-brain barrier transport
GENENTECH INC0 citations45
CHEN YVONNE
5 patentsUS8545850B2Oct 1, 2013
Anti-CD79B antibodies and immunoconjugates and methods of use
CHEN YVONNE48 citations97
US8088378B2Jan 3, 2012
Anti-CD79B antibodies and immunoconjugates and methods of use
CHEN YVONNE48 citations97
US9845355B2Dec 19, 2017
Humanized anti-CD79b antibodies and immunoconjugates and methods of use
CHEN YVONNE20 citations92
US8722857B2May 13, 2014
Anti-CD79B antibodies and immunoconjugates and methods of use
CHEN YVONNE22 citations92
US8691531B2Apr 8, 2014
Anti-CD79B antibodies and immunoconjugates and methods of use
CHEN YVONNE20 citations92
DENNIS MARK
4 patentsUS8911732B2Dec 16, 2014
Anti-mesothelin antibodies and immunoconjugates
DENNIS MARK37 citations96
US8535675B2Sep 17, 2013
Compositions and methods for the diagnosis and treatment of tumor
DENNIS MARK9 citations83
US8409579B2Apr 2, 2013
Humanized anti-FGF19 antagonists and methods using same
DENNIS MARK2 citations62
US8236307B2Aug 7, 2012
Humanized anti-FGF19 antagonists and methods using same
DENNIS MARK0 citations51
WU LAWREN
4 patentsUS8071097B2Dec 6, 2011
Apoptotic anti-IgE antibodies
WU LAWREN34 citations94
US8632775B2Jan 21, 2014
Apoptotic anti-IgE antibodies
WU LAWREN4 citations82
US8586040B2Nov 19, 2013
Methods of using apoptotic anti-IGE antibodies
WU LAWREN6 citations82
US8618274B2Dec 31, 2013
Nucleic acid encoding apoptotic anti-IgE antibodies
WU LAWREN4 citations71
PNC GLOBAL TRANSFERS INC
3 patentsUS11315092B1Apr 26, 2022
ATM-based electronic payment funding systems, methods, and interfaces
PNC GLOBAL TRANSFERS INC7 citations81
US11282053B1Mar 22, 2022
ATM-based electronic payment conversion systems, methods, and user interfaces
PNC GLOBAL TRANSFERS INC4 citations68
US12260383B2Mar 25, 2025
ATM-based electronic payment conversion systems, methods, and user interfaces
PNC GLOBAL TRANSFERS INC0 citations58